首页 >
法规速递
-
Document: European Medicines Agency pre-authorisation procedural advice for users of the centralised procedure-2025/12/15
2025-12-16查看详情 > -
国家药监局综合司关于2026年医疗器械行业标准制修订计划项目公示-2026/1/28
2026-01-28查看详情 > -
Page: Orphan designation: Overview-2026/3/6
2026-03-09查看详情 > -
国家药监局关于修订注射用过氧化碳酰胺说明书的公告（2026年第35号）-2026/4/7
2026-04-08查看详情 > -
Document: Start of procedure: Type II Variation - Extension of indication under evaluation by the CHMP (27 March 2026 - 23 April 2026)-2026/5/19
2026-05-20查看详情 > -
Document: Highlight report - Combination Products Operational Group (COMBO) - In Vitro Diagnostics stream - June 2026-2026/7/2
2026-07-03查看详情 > -
Document: HMPC: overview of assessment work - priority list-2026/8/11
2026-08-12查看详情 > -
E19 A Selective Approach to Safety Data Collection in Specific Late-Stage Pre-Approval or Post-Approval Clinical Trials (Final)-2022/12/5
2022-12-06查看详情 > -
Scientific guideline: Concept paper on the development of a guideline on the quality aspects of mRNA vaccines-2023/6/23
2023-06-25查看详情 > -
国家药监局关于修订复方首乌地黄丸说明书的公告（2023年第160号）-2023/12/27
2024-01-03查看详情 >
